Forward Pharma A/S Statistics Share Statistics Forward Pharma A/S has 0
shares outstanding. The number of shares has increased by 1.03%
in one year.
Shares Outstanding n/a Shares Change (YoY) 1.03% Shares Change (QoQ) 1.03% Owned by Institutions (%) n/a Shares Floating 1.55M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.03K, so 0% of the outstanding
shares have been sold short.
Short Interest 4.03K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.35
Valuation Ratios The PE ratio is 6484.88 and the forward
PE ratio is null.
Forward Pharma A/S's PEG ratio is
-63.99.
PE Ratio 6484.88 Forward PE n/a PS Ratio -3104.46 Forward PS n/a PB Ratio 8.24 P/FCF Ratio -247.41 PEG Ratio -63.99
Financial Ratio History Enterprise Valuation Forward Pharma A/S has an Enterprise Value (EV) of 512.87M.
EV / Sales -2728.03 EV / EBITDA -271.07 EV / EBIT -217.41 EV / FCF -217.41
Financial Position The company has a current ratio of 117.44,
with a Debt / Equity ratio of 0.
Current Ratio 117.44 Quick Ratio 117.44 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 1.95
Financial Efficiency Return on Equity is 0.13% and Return on Invested Capital is 0.26%.
Return on Equity 0.13% Return on Assets 0.13% Return on Invested Capital 0.26% Revenue Per Employee $-47K Profits Per Employee $22.5K Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -1.98M Effective Tax Rate 104.76%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Forward Pharma A/S's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 2.83 200-Day Moving Average 4.17 Relative Strength Index (RSI) 34.95 Average Volume (20 Days) 9,843
Income Statement In the last 12 months, Forward Pharma A/S had revenue of -188K
and earned 90K
in profits. Earnings per share was 0.
Revenue -188K Gross Profit -188K Operating Income -3.87M Net Income 90K EBITDA -1.89M EBIT -3.87M Earnings Per Share (EPS) 0
Full Income Statement Balance Sheet The company has 70.77M in cash and 0 in
debt, giving a net cash position of 70.77M.
Cash & Cash Equivalents 70.77M Total Debt n/a Net Cash n/a Retained Earnings -16.72M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.36M
and capital expenditures 0, giving a free cash flow of -2.36M.
Operating Cash Flow -2.36M Capital Expenditures n/a Free Cash Flow -2.36M FCF Per Share -0.02
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 2060.64% and -47.87%.
Gross Margin 100% Operating Margin 2060.64% Pretax Margin 1006.38% Profit Margin -47.87% EBITDA Margin 1006.38% EBIT Margin 2060.64% FCF Margin 1254.79%
Dividends & Yields FWP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 0.02% FCF Yield -0.4%
Dividend Details Analyst Forecast Currently there are no analyst rating for FWP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside -100% Graham Number 0.12 Graham Upside -93.85%
Stock Splits The last stock split was on Dec 6, 2019. It was a
backward
split with a ratio of 1:7.
Last Split Date Dec 6, 2019 Split Type backward Split Ratio 1:7
Scores Altman Z-Score n/a Piotroski F-Score n/a
